Designing ofa phase 2, multicenter, randomized, placebo-controlled, double-blind study to assess the efficacy and safety of nipocalimab, an fcrn inhibitor, in adults with primary sjogren's syndrome
ARTHRITIS & RHEUMATOLOGY（2023）
关键词
FcRn, Nipocalimab, Sjogren's Syndrome
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要